Chamber and committees

I refer the member to the answer to question S6W-04154 on 17 November 2021.

In relation to other technologies that could reduce pressure on the pharmacy sector, community pharmacies have had access to NHS Near Me since 2020. This offers an additional communication tool for use with healthcare professionals and patients. Pharmacists also have access to the Emergency Care Summary and we are working with Health Boards to ensure pharmacists have appropriate access to patient information through the Clinical Portal. The ePharmacy Programme continues to oversee and develop technology used in community pharmacies to support the provision of NHS pharmaceutical care services.

All answers to written parliamentary questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.

All patient conveying vehicles including paramedic response units carry defibrillators and staff are trained to use them. Community First responder vehicles also carry defibrillators, and the Scottish Ambulance Service has access to a system which is used to direct members of public to the closest registered defibrillator.

The Scottish Government continues to work with NHS National Education for Scotland (NES) and the Royal Pharmaceutical Society in developing a joint programme to encourage more students, and not just school leavers, to consider careers in pharmacy, including ensuring the output reaches deprived and remote and rural communities.

In addition, both Schools of Pharmacy work towards the widening access targets set by the Commission on Widening Access for universities to drive forward the delivery of equal access in Scotland.

There are also wider initiatives such as The Scottish Wider Access Programme (SWAP). The partnership develops access programmes for adults returning to education, and targets adults who reside in the most disadvantaged areas of Scotland and particularly those who have no, few or out of date qualifications. This can help support people with few suitable qualifications to progress to degree level Pharmacy studies.

I refer to member to the answer to question S6W-05124 on 10 January 2022. All answers to written parliamentary questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.

The Scottish Government does not hold information on temporary closures of community pharmacies or the possible cost incurred by the NHS.

The provision of community pharmacy pharmaceutical care services are the responsibility of territorial Health Boards as set out in the National Health Service (Pharmaceutical Services) (Scotland) Regulations 2009. Any challenges faced by community pharmacies in ensuring the safe and effective dispensing of treatments should be discussed with the local Health Board.

Following a successful three year pilot, in 2013 the four nations agreed to a 10 year grant to support those affected by the thalidomide drug. Over the last nine years the Scottish Government has issued a total of £11.512 million to the Thalidomide Trust, for distribution to Scottish survivors. A further £1.636 Million is projected for the final year (2022-23), bringing total funding to £13.15 million.

A variety of risk assessments are undertaken across all wards in the Hospital, including 4a and 4b, covering social distancing, hand hygiene, infection control precautions (SICPs) audits every 6 months, patient placement, and the verification of the specialist ventilation systems in ward 4b. The new and innovative Infection Prevention and Control (IPC) dashboard available to all staff enables real time review of IPC data, and allows for a quick and effective response to any risks reported.

The Scottish Government continues to work with Health Boards, Community Pharmacy Scotland and other stakeholders across the sector to address any challenges faced by temporary closures of community pharmacies.

The Chief Pharmaceutical Officer has committed to putting together a workforce forum which will meet in early 2022. The forum will look at the workforce challenges and bring together stakeholders from pharmacy education and pharmacy service provision to set a strategic workforce plan for the profession.

The information requested regarding whether the Health and Safety Executive (HSE) has invoked a Divisional Major Incident Response Plan, in relation to deaths due to hospital associated infection at the Queen Elizabeth University Hospital, is not centrally held by the Scottish Government.

Health and safety at work is a reserved matter. HSE has confirmed that the issues raised with them did not meet the criteria for a ‘Divisional Major Incident’ as outlined in their published response plans og-00076-appendix-4.pdf (hse.gov.uk) .

The information requested regarding whether the Health and Safety Executive (HSE) has carried out any investigation into deaths due to hospital-acquired infection at the Queen Elizabeth University Hospital is not centrally held by the Scottish Government.

Health and safety at work is a reserved matter. HSE has confirmed that their published policy is generally not to investigate hospital acquired infections Who regulates health care (hse.gov.uk) . They have not investigated deaths at the Queen Elizabeth University Hospital that may have been caused by a hospital associated infection.

HSE did however carry out an investigation into concerns raised with them in December 2019 about the ventilation within two wards at the Queen Elizabeth University Hospital and the control of legionella in water systems across the hospital.

HSE was satisfied with the control of legionella but wrote to the Chief Executive of Greater Glasgow Health Board/NHS Greater Glasgow and Clyde requesting improvements to the ventilation systems. An Improvement Notice was served in relation to the ventilation system within Ward 4C.

Further information is available on the NHS GGC webpage: https://www.nhsggc.org.uk/about-us/media-centre/news/2019/12/hse-improvement-notice/ . The Improvement Notice is being appealed by the Health Board. However, HSE is satisfied that appropriate remedial action has been taken.